Related Experiment Videos
Chlamydia trachomatis (L2 serovar) binds to distinct subpopulations of human peripheral blood leukocytes
Insights
Chlamydia trachomatis preferentially binds to human B lymphocytes, not T cells, in infants with pneumonitis. This binding is a key step in understanding how this bacterium interacts with immune cells.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Infants with Chlamydia trachomatis pneumonitis show elevated B lymphocytes but not T lymphocytes.
- Chlamydiae induce B cell proliferation and differentiation into immunoglobulin-secreting cells in vitro, especially with T cell presence.
Purpose of the Study:
- To investigate the binding interactions between Chlamydia trachomatis (L2 serovar) and human peripheral blood lymphocytes.
- To establish a correlation between the physical interaction of C. trachomatis with lymphocytes and its immunostimulatory activities.
Main Methods:
- Flow cytometry was used to quantify the binding of C. trachomatis (L2 serovar) to human peripheral blood B cells, T cells, monocytes, and granulocytes.
- In vitro cultures were performed to assess chlamydial uptake and growth within B cells and monocytes.
- The percentage of cells associated with bacteria was monitored over time in culture.
Main Results:
- C. trachomatis (L2 serovar) preferentially binds to approximately 50% of human peripheral blood B lymphocytes, with minimal binding to T cells.
- Monocytes and granulocytes bind and ingest chlamydiae, but B cells do not exhibit significant uptake.
- Limited chlamydial growth (<0.5% inclusion-containing cells) was observed in monocytes, with a notable decrease in bacteria-associated cells after culture.
Conclusions:
- This study provides the first evidence of C. trachomatis (L2 serovar) binding to lymphocytes.
- The preferential binding to B lymphocytes suggests a specific interaction mechanism relevant to C. trachomatis infections.
- These findings represent a crucial step in linking bacterial-host cell interactions with observed immune responses in vitro.
Abstract:
We have previously shown that infants with pneumonitis caused by Chlamydia trachomatis, an obligate intracellular bacterium, possess increased percentages of B lymphocytes but not T lymphocytes in their peripheral blood. It was then demonstrated that chlamydiae induce proliferation in vitro of human peripheral blood B lymphocytes and, in the presence of T cells, differentiation of B cells to immunoglobulin-secreting cells. In this study, we show that C. trachomatis (L2 serovar) binds preferentially to 50% of human B lymphocytes from peripheral blood but only to a small percentage, if any, of T cells. Both monocytes and granulocytes bind and ingest chlamydiae. Despite chlamydial binding to B cells and ingestion by monocytes, no uptake by B cells and limited growth (fewer than 0.5% inclusion-containing cells) in monocytes occur. There is a dramatic decrease in the percentage of cells associated with the bacteria after culture. These results are the first demonstration of binding of C. trachomatis (L2 serovar) to lymphocytes and represent a direct step toward correlating physical interactions between bacteria and lymphocytes with specific immunostimulatory activities in vitro.